Annals of Clinical and Translational Neurology

Papers
(The H4-Index of Annals of Clinical and Translational Neurology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information111
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels84
The case of a 49‐year‐old man with involuntary toe movements75
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes68
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression59
Association of serum Spp1 levels with disease progression in ALS and SBMA59
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration56
Peripheral nervous system manifestations of MOG antibody associated disease56
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation53
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan52
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke47
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome42
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study41
Cognitive impairment in pulmonary arterial hypertension41
Discrepant expressive language lateralization in children and adolescents with epilepsy38
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury36
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients36
Order from chaos: Using CSF proteomics to predict ALS progression36
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states36
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies35
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA34
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica34
SARSCoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis33
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D33
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes33
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia33
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study33
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease32
Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis32
Issue Information32
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)31
Dose–exposure–efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy31
The case of a 60‐year‐old man with decline in job performance and changes in personality and judgment31
0.036785125732422